[IMATINIB INDUCED EDEMA].
Harefuah
; 163(6): 397, 2024 Jun.
Article
in He
| MEDLINE
| ID: mdl-38884296
ABSTRACT
INTRODUCTION:
Imatinib is a tyrosine kinase inhibitor and is used for the treatment of chronic myeloid leukemia (CML) since 2002. We present a patient who suffered from fluid retention and periorbital edema secondary to this drug.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Protein Kinase Inhibitors
/
Edema
/
Imatinib Mesylate
/
Antineoplastic Agents
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
He
Journal:
Harefuah
Year:
2024
Document type:
Article
Country of publication: